REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Grupo Farmaceutico de Colombia L.G.F.C. Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Laboratorio Grupo Farmaceutico de Colombia L.G.F.C. Sas Profile Updated: January 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Grupo Farmaceutico de Colombia L.G.F.C. Sas is an enterprise based in Colombia. Its main office is in Floridablanca. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on March 02, 2011. It currently has a total number of 6 (2023) employees. The latest financial highlights indicate a net sales revenue drop of 82.59% in 2023. A negative growth of 20.62% was recorded in its total assets.

Headquarters
Carrera 33 # 110 - 21 Piso 1
Floridablanca; Santander;

Contact Details: Purchase the Laboratorio Grupo Farmaceutico de Colombia L.G.F.C. Sas report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Grupo Farmaceutico de Colombia L.G.F.C. Sas report to view the information.
Outstanding Shares:
Purchase the Laboratorio Grupo Farmaceutico de Colombia L.G.F.C. Sas report to view the information.
Incorporation Date:
March 02, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Grupo Farmaceutico de Colombia L.G.F.C. Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-82.59%
Total operating revenue
-82.59%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-20.62%
Total equity
-10.69%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
18.59%
Quick Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?